Structure

Physi-Chem Properties

Molecular Weight:  500.23
Volume:  527.517
LogP:  4.818
LogD:  4.206
LogS:  -4.824
# Rotatable Bonds:  13
TPSA:  93.73
# H-Bond Aceptor:  7
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.424
Synthetic Accessibility Score:  2.997
Fsp3:  0.3
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.912
MDCK Permeability:  0.00014855047629680485
Pgp-inhibitor:  0.985
Pgp-substrate:  0.731
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.023
30% Bioavailability (F30%):  0.049

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.518
Plasma Protein Binding (PPB):  96.66651916503906%
Volume Distribution (VD):  0.735
Pgp-substrate:  1.5047794580459595%

ADMET: Metabolism

CYP1A2-inhibitor:  0.084
CYP1A2-substrate:  0.174
CYP2C19-inhibitor:  0.944
CYP2C19-substrate:  0.515
CYP2C9-inhibitor:  0.88
CYP2C9-substrate:  0.18
CYP2D6-inhibitor:  0.895
CYP2D6-substrate:  0.768
CYP3A4-inhibitor:  0.959
CYP3A4-substrate:  0.771

ADMET: Excretion

Clearance (CL):  2.513
Half-life (T1/2):  0.109

ADMET: Toxicity

hERG Blockers:  0.603
Human Hepatotoxicity (H-HT):  0.804
Drug-inuced Liver Injury (DILI):  0.942
AMES Toxicity:  0.715
Rat Oral Acute Toxicity:  0.82
Maximum Recommended Daily Dose:  0.492
Skin Sensitization:  0.041
Carcinogencity:  0.193
Eye Corrosion:  0.003
Eye Irritation:  0.007
Respiratory Toxicity:  0.031

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC246913

Natural Product ID:  NPC246913
Common Name*:   Ixorapeptide I
IUPAC Name:   methyl (2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylbutanoyl]amino]-3-phenylpropanoate
Synonyms:   Ixorapeptide I
Standard InCHIKey:  MOTXJERIRYLGLC-SVBPBHIXSA-N
Standard InCHI:  InChI=1S/C30H32N2O5/c1-19(2)27(28(33)31-26(29(34)36-3)17-20-11-5-4-6-12-20)32-30(35)37-18-25-23-15-9-7-13-21(23)22-14-8-10-16-24(22)25/h4-16,19,25-27H,17-18H2,1-3H3,(H,31,33)(H,32,35)/t26-,27-/m0/s1
SMILES:  CC(C)[C@@H](C(=N[C@@H](Cc1ccccc1)C(=O)OC)O)N=C(O)OCC1c2ccccc2-c2ccccc12
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1288061
PubChem CID:   15484640
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0000013] Amino acids, peptides, and analogues
          • [CHEMONTID:0000348] Peptides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6876 Ixora coccinea Species Rubiaceae Eukaryota aerial parts collected on the campus of Kaohsiung Medical University, Taiwan 2007-Oct PMID[21106454]
NPO6876 Ixora coccinea Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell Line HepG2 Homo sapiens IC50 > 20.0 ug.mL-1 PMID[456132]
NPT1031 Cell Line Ca9-22 Homo sapiens IC50 = 20.0 ug.mL-1 PMID[456132]
NPT81 Cell Line A549 Homo sapiens IC50 > 20.0 ug.mL-1 PMID[456132]
NPT83 Cell Line MCF7 Homo sapiens IC50 > 20.0 ug.mL-1 PMID[456132]
NPT82 Cell Line MDA-MB-231 Homo sapiens IC50 > 20.0 ug.mL-1 PMID[456132]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 3.36 ug.mL-1 PMID[456132]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 29.52 ug.mL-1 PMID[456132]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 20.51 ug.mL-1 PMID[456132]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC246913 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8321 Intermediate Similarity NPC4974
0.8062 Intermediate Similarity NPC310467
0.7984 Intermediate Similarity NPC169328
0.7926 Intermediate Similarity NPC210950
0.7926 Intermediate Similarity NPC199738
0.791 Intermediate Similarity NPC47667
0.7823 Intermediate Similarity NPC470274
0.7803 Intermediate Similarity NPC190663
0.7761 Intermediate Similarity NPC35996
0.7734 Intermediate Similarity NPC474584
0.7717 Intermediate Similarity NPC319579
0.7687 Intermediate Similarity NPC160493
0.7669 Intermediate Similarity NPC80150
0.7669 Intermediate Similarity NPC45777
0.7669 Intermediate Similarity NPC477061
0.7652 Intermediate Similarity NPC237420
0.7643 Intermediate Similarity NPC244866
0.7557 Intermediate Similarity NPC197470
0.7537 Intermediate Similarity NPC478016
0.7537 Intermediate Similarity NPC478014
0.7537 Intermediate Similarity NPC478015
0.748 Intermediate Similarity NPC12730
0.7402 Intermediate Similarity NPC327481
0.7397 Intermediate Similarity NPC161069
0.7388 Intermediate Similarity NPC314992
0.7357 Intermediate Similarity NPC473322
0.7357 Intermediate Similarity NPC296712
0.7338 Intermediate Similarity NPC477937
0.7305 Intermediate Similarity NPC478147
0.7302 Intermediate Similarity NPC164859
0.7297 Intermediate Similarity NPC473922
0.7266 Intermediate Similarity NPC191215
0.7266 Intermediate Similarity NPC274089
0.7254 Intermediate Similarity NPC255447
0.7252 Intermediate Similarity NPC329011
0.7246 Intermediate Similarity NPC476278
0.7241 Intermediate Similarity NPC127741
0.7239 Intermediate Similarity NPC2265
0.72 Intermediate Similarity NPC138775
0.7197 Intermediate Similarity NPC273814
0.7185 Intermediate Similarity NPC470545
0.7181 Intermediate Similarity NPC209509
0.7163 Intermediate Similarity NPC89923
0.7163 Intermediate Similarity NPC105114
0.7163 Intermediate Similarity NPC239990
0.7163 Intermediate Similarity NPC152850
0.7163 Intermediate Similarity NPC71933
0.7153 Intermediate Similarity NPC476183
0.7152 Intermediate Similarity NPC476750
0.7143 Intermediate Similarity NPC153007
0.7132 Intermediate Similarity NPC470546
0.7115 Intermediate Similarity NPC93343
0.7113 Intermediate Similarity NPC111428
0.7111 Intermediate Similarity NPC470544
0.7101 Intermediate Similarity NPC476281
0.7101 Intermediate Similarity NPC476184
0.7097 Intermediate Similarity NPC25565
0.7095 Intermediate Similarity NPC263493
0.7095 Intermediate Similarity NPC269398
0.7092 Intermediate Similarity NPC136453
0.7083 Intermediate Similarity NPC326966
0.7078 Intermediate Similarity NPC472761
0.7071 Intermediate Similarity NPC473938
0.7063 Intermediate Similarity NPC325651
0.704 Intermediate Similarity NPC475439
0.704 Intermediate Similarity NPC473501
0.704 Intermediate Similarity NPC311242
0.7037 Intermediate Similarity NPC188010
0.7032 Intermediate Similarity NPC275839
0.7014 Intermediate Similarity NPC183722
0.7014 Intermediate Similarity NPC157311
0.7007 Intermediate Similarity NPC6570
0.7006 Intermediate Similarity NPC56635
0.7 Intermediate Similarity NPC94751
0.7 Intermediate Similarity NPC142326
0.7 Intermediate Similarity NPC476978
0.6977 Remote Similarity NPC194390
0.6977 Remote Similarity NPC224610
0.6977 Remote Similarity NPC88267
0.6977 Remote Similarity NPC113326
0.6974 Remote Similarity NPC225648
0.6974 Remote Similarity NPC329761
0.6974 Remote Similarity NPC475578
0.6968 Remote Similarity NPC122590
0.6966 Remote Similarity NPC8761
0.6966 Remote Similarity NPC45191
0.6966 Remote Similarity NPC44805
0.6963 Remote Similarity NPC33742
0.6954 Remote Similarity NPC5620
0.695 Remote Similarity NPC476241
0.695 Remote Similarity NPC476260
0.6933 Remote Similarity NPC91953
0.6933 Remote Similarity NPC139326
0.6933 Remote Similarity NPC476749
0.6929 Remote Similarity NPC213126
0.6929 Remote Similarity NPC291027
0.6929 Remote Similarity NPC84281
0.6929 Remote Similarity NPC317474
0.6929 Remote Similarity NPC142577
0.6929 Remote Similarity NPC7435
0.6929 Remote Similarity NPC169485
0.6928 Remote Similarity NPC105717
0.6923 Remote Similarity NPC476353
0.6918 Remote Similarity NPC313663
0.6908 Remote Similarity NPC262077
0.6908 Remote Similarity NPC314114
0.6901 Remote Similarity NPC476125
0.6901 Remote Similarity NPC476179
0.6899 Remote Similarity NPC471317
0.6892 Remote Similarity NPC471264
0.6892 Remote Similarity NPC471265
0.6892 Remote Similarity NPC478140
0.6889 Remote Similarity NPC35850
0.6889 Remote Similarity NPC276949
0.688 Remote Similarity NPC58674
0.688 Remote Similarity NPC303045
0.688 Remote Similarity NPC161972
0.6879 Remote Similarity NPC6975
0.6875 Remote Similarity NPC116057
0.6875 Remote Similarity NPC472413
0.6871 Remote Similarity NPC64897
0.6871 Remote Similarity NPC90693
0.6871 Remote Similarity NPC132847
0.6867 Remote Similarity NPC197921
0.6867 Remote Similarity NPC239770
0.6863 Remote Similarity NPC328824
0.6863 Remote Similarity NPC145113
0.6857 Remote Similarity NPC71684
0.6849 Remote Similarity NPC246079
0.6846 Remote Similarity NPC98424
0.6846 Remote Similarity NPC132636
0.6846 Remote Similarity NPC470884
0.6846 Remote Similarity NPC92784
0.6846 Remote Similarity NPC178662
0.6846 Remote Similarity NPC476133
0.6835 Remote Similarity NPC319950
0.6829 Remote Similarity NPC258627
0.6829 Remote Similarity NPC172128
0.6828 Remote Similarity NPC69496
0.6825 Remote Similarity NPC261947
0.6824 Remote Similarity NPC314835
0.6809 Remote Similarity NPC474862
0.6809 Remote Similarity NPC109151
0.6803 Remote Similarity NPC233910
0.6803 Remote Similarity NPC470392
0.6803 Remote Similarity NPC245836
0.68 Remote Similarity NPC239762
0.68 Remote Similarity NPC163392
0.6795 Remote Similarity NPC162104
0.6794 Remote Similarity NPC211551
0.6788 Remote Similarity NPC9274
0.6786 Remote Similarity NPC200964
0.6783 Remote Similarity NPC101719
0.6783 Remote Similarity NPC472414
0.6779 Remote Similarity NPC208725
0.6779 Remote Similarity NPC68865
0.6774 Remote Similarity NPC245259
0.6774 Remote Similarity NPC2501
0.6774 Remote Similarity NPC129666
0.6774 Remote Similarity NPC476757
0.6772 Remote Similarity NPC122493
0.6772 Remote Similarity NPC10781
0.6772 Remote Similarity NPC293628
0.6772 Remote Similarity NPC324569
0.677 Remote Similarity NPC73644
0.6761 Remote Similarity NPC472415
0.6753 Remote Similarity NPC135121
0.6752 Remote Similarity NPC286551
0.6746 Remote Similarity NPC172925
0.6744 Remote Similarity NPC128248
0.6744 Remote Similarity NPC469457
0.6744 Remote Similarity NPC264728
0.6744 Remote Similarity NPC136810
0.6744 Remote Similarity NPC133809
0.6738 Remote Similarity NPC202521
0.6735 Remote Similarity NPC42423
0.6719 Remote Similarity NPC322598
0.6713 Remote Similarity NPC222466
0.6712 Remote Similarity NPC200589
0.6711 Remote Similarity NPC469360
0.6708 Remote Similarity NPC235460
0.6707 Remote Similarity NPC317725
0.6707 Remote Similarity NPC326407
0.6692 Remote Similarity NPC21929
0.6692 Remote Similarity NPC318154
0.6691 Remote Similarity NPC45794
0.669 Remote Similarity NPC27581
0.6689 Remote Similarity NPC46098
0.6689 Remote Similarity NPC268841
0.6689 Remote Similarity NPC307357
0.6688 Remote Similarity NPC262216
0.6688 Remote Similarity NPC49565
0.6688 Remote Similarity NPC233702
0.6687 Remote Similarity NPC217801
0.6667 Remote Similarity NPC474847
0.6667 Remote Similarity NPC476990
0.6667 Remote Similarity NPC67043
0.6667 Remote Similarity NPC471186
0.6667 Remote Similarity NPC221825
0.6667 Remote Similarity NPC6913

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC246913 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8943 High Similarity NPD4479 Discontinued
0.8661 High Similarity NPD5618 Discontinued
0.8145 Intermediate Similarity NPD3644 Approved
0.8145 Intermediate Similarity NPD3642 Approved
0.8145 Intermediate Similarity NPD3643 Approved
0.803 Intermediate Similarity NPD5108 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD5981 Approved
0.7754 Intermediate Similarity NPD4738 Phase 2
0.7612 Intermediate Similarity NPD2956 Clinical (unspecified phase)
0.7557 Intermediate Similarity NPD1348 Approved
0.7552 Intermediate Similarity NPD6852 Discontinued
0.7551 Intermediate Similarity NPD8323 Discontinued
0.7465 Intermediate Similarity NPD6623 Phase 3
0.7463 Intermediate Similarity NPD4209 Clinical (unspecified phase)
0.7388 Intermediate Similarity NPD2217 Approved
0.7388 Intermediate Similarity NPD2218 Phase 2
0.7379 Intermediate Similarity NPD6865 Phase 2
0.7379 Intermediate Similarity NPD6864 Phase 2
0.7375 Intermediate Similarity NPD7997 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD3881 Discontinued
0.7333 Intermediate Similarity NPD4504 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD2584 Suspended
0.7246 Intermediate Similarity NPD3880 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD4335 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD8265 Approved
0.7188 Intermediate Similarity NPD1040 Phase 2
0.7185 Intermediate Similarity NPD6065 Approved
0.7181 Intermediate Similarity NPD6860 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD2650 Approved
0.7143 Intermediate Similarity NPD2652 Approved
0.7143 Intermediate Similarity NPD4760 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD7596 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD7828 Discontinued
0.7111 Intermediate Similarity NPD4574 Approved
0.7111 Intermediate Similarity NPD4576 Approved
0.7095 Intermediate Similarity NPD6897 Clinical (unspecified phase)
0.7092 Intermediate Similarity NPD6302 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD7602 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD7740 Clinical (unspecified phase)
0.7077 Intermediate Similarity NPD6038 Clinical (unspecified phase)
0.7075 Intermediate Similarity NPD6294 Approved
0.7075 Intermediate Similarity NPD6295 Approved
0.7055 Intermediate Similarity NPD8643 Discontinued
0.7047 Intermediate Similarity NPD7720 Phase 2
0.7037 Intermediate Similarity NPD4031 Approved
0.7037 Intermediate Similarity NPD4032 Approved
0.7034 Intermediate Similarity NPD8118 Discontinued
0.7007 Intermediate Similarity NPD2617 Discontinued
0.7 Intermediate Similarity NPD6624 Discontinued
0.6963 Remote Similarity NPD4766 Approved
0.6959 Remote Similarity NPD8154 Clinical (unspecified phase)
0.6944 Remote Similarity NPD5202 Clinical (unspecified phase)
0.694 Remote Similarity NPD2607 Approved
0.6934 Remote Similarity NPD7522 Discontinued
0.6929 Remote Similarity NPD2608 Approved
0.6929 Remote Similarity NPD3132 Approved
0.6929 Remote Similarity NPD4215 Approved
0.6929 Remote Similarity NPD2610 Approved
0.6929 Remote Similarity NPD2609 Approved
0.6929 Remote Similarity NPD2611 Approved
0.6929 Remote Similarity NPD3603 Phase 3
0.6929 Remote Similarity NPD4480 Approved
0.6929 Remote Similarity NPD4218 Approved
0.6929 Remote Similarity NPD3131 Approved
0.6929 Remote Similarity NPD4217 Approved
0.6929 Remote Similarity NPD7437 Approved
0.6929 Remote Similarity NPD7436 Approved
0.6929 Remote Similarity NPD4216 Approved
0.6929 Remote Similarity NPD2612 Approved
0.6918 Remote Similarity NPD7715 Approved
0.6918 Remote Similarity NPD7714 Approved
0.6903 Remote Similarity NPD6390 Discontinued
0.6897 Remote Similarity NPD3136 Phase 2
0.6892 Remote Similarity NPD8172 Phase 2
0.6892 Remote Similarity NPD8173 Phase 2
0.6884 Remote Similarity NPD6093 Discontinued
0.6871 Remote Similarity NPD8416 Discontinued
0.6867 Remote Similarity NPD7450 Phase 2
0.6867 Remote Similarity NPD7512 Approved
0.6867 Remote Similarity NPD7511 Approved
0.6863 Remote Similarity NPD6552 Clinical (unspecified phase)
0.6861 Remote Similarity NPD5162 Approved
0.6855 Remote Similarity NPD7011 Discontinued
0.6855 Remote Similarity NPD8019 Approved
0.6853 Remote Similarity NPD6563 Approved
0.6853 Remote Similarity NPD6564 Approved
0.6853 Remote Similarity NPD6565 Approved
0.6849 Remote Similarity NPD4619 Approved
0.6849 Remote Similarity NPD5581 Approved
0.6849 Remote Similarity NPD4621 Approved
0.6842 Remote Similarity NPD4233 Approved
0.6842 Remote Similarity NPD3646 Clinical (unspecified phase)
0.6842 Remote Similarity NPD4234 Approved
0.6835 Remote Similarity NPD6994 Approved
0.6835 Remote Similarity NPD8417 Discontinued
0.6835 Remote Similarity NPD6993 Approved
0.6828 Remote Similarity NPD4125 Approved
0.6828 Remote Similarity NPD2613 Approved
0.6828 Remote Similarity NPD6359 Clinical (unspecified phase)
0.6825 Remote Similarity NPD2895 Discontinued
0.6815 Remote Similarity NPD8315 Phase 1
0.6809 Remote Similarity NPD4806 Approved
0.6809 Remote Similarity NPD4807 Approved
0.6803 Remote Similarity NPD3088 Approved
0.6803 Remote Similarity NPD3614 Approved
0.6803 Remote Similarity NPD3090 Approved
0.6803 Remote Similarity NPD2573 Approved
0.6803 Remote Similarity NPD3615 Approved
0.6803 Remote Similarity NPD4746 Phase 3
0.6803 Remote Similarity NPD2572 Clinical (unspecified phase)
0.6803 Remote Similarity NPD2566 Approved
0.6803 Remote Similarity NPD3089 Approved
0.6803 Remote Similarity NPD3616 Approved
0.6803 Remote Similarity NPD2574 Discontinued
0.6803 Remote Similarity NPD3087 Approved
0.6803 Remote Similarity NPD4745 Approved
0.6803 Remote Similarity NPD5729 Clinical (unspecified phase)
0.6803 Remote Similarity NPD2570 Approved
0.6803 Remote Similarity NPD2571 Approved
0.6797 Remote Similarity NPD7253 Phase 3
0.6797 Remote Similarity NPD3400 Discontinued
0.6795 Remote Similarity NPD7613 Discontinued
0.6794 Remote Similarity NPD999 Phase 2
0.6788 Remote Similarity NPD7508 Discontinued
0.6779 Remote Similarity NPD6073 Approved
0.6774 Remote Similarity NPD8165 Discontinued
0.6772 Remote Similarity NPD9566 Approved
0.6772 Remote Similarity NPD2487 Clinical (unspecified phase)
0.6765 Remote Similarity NPD1374 Approved
0.6765 Remote Similarity NPD1371 Approved
0.6765 Remote Similarity NPD1373 Approved
0.6765 Remote Similarity NPD1370 Approved
0.6757 Remote Similarity NPD6346 Approved
0.6746 Remote Similarity NPD4814 Discontinued
0.6746 Remote Similarity NPD688 Clinical (unspecified phase)
0.6742 Remote Similarity NPD5705 Approved
0.6742 Remote Similarity NPD5704 Approved
0.6742 Remote Similarity NPD5706 Approved
0.6739 Remote Similarity NPD1841 Clinical (unspecified phase)
0.6738 Remote Similarity NPD4106 Approved
0.6738 Remote Similarity NPD4135 Approved
0.6738 Remote Similarity NPD4136 Approved
0.6735 Remote Similarity NPD8011 Discontinued
0.6713 Remote Similarity NPD4677 Discontinued
0.6712 Remote Similarity NPD5201 Approved
0.6712 Remote Similarity NPD4617 Approved
0.6712 Remote Similarity NPD5203 Approved
0.6712 Remote Similarity NPD4620 Approved
0.6711 Remote Similarity NPD4684 Phase 3
0.6711 Remote Similarity NPD4152 Approved
0.6711 Remote Similarity NPD4685 Phase 3
0.6711 Remote Similarity NPD4686 Approved
0.6708 Remote Similarity NPD7599 Phase 2
0.6707 Remote Similarity NPD6746 Phase 2
0.6693 Remote Similarity NPD1989 Approved
0.6691 Remote Similarity NPD1837 Clinical (unspecified phase)
0.6691 Remote Similarity NPD6360 Discontinued
0.669 Remote Similarity NPD3608 Clinical (unspecified phase)
0.6687 Remote Similarity NPD7749 Clinical (unspecified phase)
0.6687 Remote Similarity NPD7105 Phase 1
0.6667 Remote Similarity NPD6681 Discovery
0.6667 Remote Similarity NPD7600 Phase 2
0.6667 Remote Similarity NPD6919 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6325 Discontinued
0.6667 Remote Similarity NPD5578 Approved
0.6667 Remote Similarity NPD5725 Approved
0.6667 Remote Similarity NPD5577 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5717 Approved
0.6667 Remote Similarity NPD7510 Approved
0.6667 Remote Similarity NPD1018 Approved
0.6645 Remote Similarity NPD4172 Approved
0.6645 Remote Similarity NPD4173 Approved
0.6644 Remote Similarity NPD5121 Approved
0.6644 Remote Similarity NPD5120 Approved
0.6644 Remote Similarity NPD7084 Phase 3
0.6644 Remote Similarity NPD4175 Approved
0.6644 Remote Similarity NPD5204 Approved
0.6644 Remote Similarity NPD5119 Approved
0.6644 Remote Similarity NPD3626 Phase 3
0.6644 Remote Similarity NPD5323 Approved
0.6644 Remote Similarity NPD5759 Approved
0.6644 Remote Similarity NPD4177 Approved
0.6642 Remote Similarity NPD3598 Phase 3
0.6627 Remote Similarity NPD7795 Phase 2
0.6626 Remote Similarity NPD8351 Phase 2
0.6623 Remote Similarity NPD8147 Approved
0.6623 Remote Similarity NPD8148 Approved
0.6622 Remote Similarity NPD5299 Approved
0.6619 Remote Similarity NPD6775 Clinical (unspecified phase)
0.6619 Remote Similarity NPD3123 Discovery
0.66 Remote Similarity NPD7113 Clinical (unspecified phase)
0.6597 Remote Similarity NPD182 Clinical (unspecified phase)
0.6596 Remote Similarity NPD4105 Approved
0.6596 Remote Similarity NPD4102 Approved
0.6593 Remote Similarity NPD1752 Approved
0.6593 Remote Similarity NPD1756 Approved
0.6589 Remote Similarity NPD253 Approved
0.6587 Remote Similarity NPD6690 Approved
0.6581 Remote Similarity NPD7488 Clinical (unspecified phase)
0.6579 Remote Similarity NPD6866 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data